Registration FormUnmasking the “Great Masquerader”: Presenting Real World Cases ofAL Amyloidosis

Registration Form

Unmasking the “Great Masquerader”: Presenting Real World Cases of

AL Amyloidosis

Welcome!

Please register below to access the webinar.

Once you submit, you will be redirected to the webinar recording and evaluation to obtain CME/CNE credit.

**If you would like the recording link to be sent to you, kindly check "send me a copy of my responses" at the bottom of this form.**

First Name*

Last Name*

Email Address*

City*

State/Province*

Select

Country/Region*

Phone

Occupation*

Select

Organization

(Please provide the full organization name)

Practice Setting*

Select

Professional Degree*

Select

Gender*

Select

Primary Care*

Select

Medical Specialist*

Select

Number of Years in Practice:*

_________ years

Self-rating:*

Select

Pre-Webinar Questions

Please answer the questions below to measure the knowledge gained following the webinar and qualify for CME/CNE credit.

1.*

Which are the two most common amyloid subtypes that lead to cardiac amyloidosis?

Select

2.*

The cardiac biomarker-based Mayo Staging system provides the following information:

Select

3.*

Which of the following is the most important determinant of survival in patients with AL amyloidosis?

Select

4.*

Select the correct statement regarding the pathophysiology of AL amyloidosis:

Select

5.*

Which of the following is true regarding diagnostic delays in patients with AL amyloidosis?

Select

6.*

The following finding should raise the suspicion of cardiac amyloidosis:

Select

7.*

Patients with AL amyloidosis can present with the following signs and symptoms:

Select

8.*

Diagnostic criteria of AL amyloidosis include:

Select

9.*

Choose the correct criteria for cardiac response to treatment in AL amyloidosis

Select

10.*

Which of the following statement is true regarding hematologic response to treatment in AL amyloidosis?

Select

11.*

What statement is true regarding the management of patients with AL amyloidosis?

Select

12.*

Goals of treatment include:

Select

Privacy Notice|Report Abuse

**Pre-Webinar Questions**

Pre-Webinar Questions